Home
overview

 

SMi’s 4th Annual Conference
3D Cell Culture
February 19-20, 2020 | London, Copthorne Tara, United Kingdom
-------------------------------------------------------------------------

Cell Culture in an important tool for research and development within the life science industry. OThe global 3D Cell Culture Market market is valued at USD 1069.28 Million and is expected to grow with a CAGR of 25.31% over the forecast period. Researchers globally are realizing the potential of 3D cell culture for various applications, including models for personalized medicine, complex and multi-cell type models, translation and clinical and industrial applications.


Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.


SMi’s 3D Cell Culture conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.
 

  • Learn from leading pharma companies to benchmark against their applications of 3D technology
  • Explore case studies of 3D cell culture, high throughput screening, imaging and microphysiological systems in industry
  • Hear about the latest technology advances allowing 3D bioprinting to revolutionize in vitro models
  • Network with the key industry players developing the use of bioprinting as part of their R&D
  • Understand novel applications of 3D bioprinting for in vitro models, regenerative medicine and screening
     

 

Who Should Attend
Executives, Directors, VPs, Heads, Principals, Managers of:

  • Cell Technology
  • Lab Head Lead Discovery
  • High Throughput Screening
  • Research and Development
  • Disease Models
  • Cell Biology & Tissue Engineering
  • Translational Science
  • Complex In Vitro Models
  • Cell and Molecular Scientist
  • Systems Biology
  • Drug Discovery

Previous attendees include:

4D Molecular Therapeutics; Aber Instruments Ltd; AstraZeneca; AstraZeneca IMED Biotech Unit; Aurelia Bioscience; Axol Bioscience Ltd ; Cellbox Solutions GmbH; CelVivo ICS; Chr. Hansen A/S; Contipro a. s. ; Daiichi-Sankyo Europe; Danisco Sweeteners Oy; Drug Target Review; Electrospinning Company; Enplas Europe Ltd; GlaxoSmithKline; GSK; Hubrecht Institute; Hubrecht Organold Technology; Idorsia Pharmaceuticals Ltd; InoCure s.r.o.; Integra NeuroSciences; Jellagen; Jellagen Pty Ltd; Kugelmeiers; Manchester BIOGEL; Medicines & Healthcare products Regulatory Agency (MHRA); Medicines Discovery Catapult; MedImmune; Merck KGaA; Mimetas; Molecular Devices (UK) Ltd; Nc3Rs; Novo Nordisk; Plasticell Ltd; Poietis; Princess Maxima Center; Promega; Roche; Sartorius; Sartorius-Stedim Biotech; Tel Aviv University; The Francis Crick Institute; The Institute Of Cancer Research; U.S. Food and Drug Administration; Unilever Research Laboratory; University of Durham; University Of Southampton; University Of Strathclyde; Zurich University of Applied Sciences;

Conference programme

8:30 Registration & Coffee

9:00 Chairs' Opening Remarks

Stefan Przyborski

Stefan Przyborski, Professor of Cell Technology, Durham University
View Bio

Philip Hewitt

Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
View Bio

9:10 The Development and Application of 3D Culture Techniques to Construct Models of Human Tissues

Stefan Przyborski

Stefan Przyborski, Professor of Cell Technology, Durham University
View Bio

• Overview of 3D cell culture technologies;
• Impact and importance of 3D cell culture;
• Beyond 3D cell culture as a technique, applications to building human tissues in vitro;
• New innovations and developments to further enhance 3D technology

9:50 Organ-on-a-chip: Can we finally replace animals in pharmaceutical research

Philip Hewitt

Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
View Bio

• Development of human, translatable in vitro MPS models
• Status of OOAC field; current models and industry “validation”
• Context of use: focus on safety testing
• Future: can we replace animals or even clinical trials?
 

10:30 Morning Coffee

11:00 Complex In Vitro Models for preclinical Oncology drug development

Jason Ekert

Jason Ekert, Head of Complex In Vitro Models, GlaxoSmithKline
View Bio

  • Characterization and validation criteria for Oncology models
  • Case studies- 
  • Avascular and vascular microfluidic tumor models
  • Tumor Organoids for combination drug screening
  • Future direction
     
  • 11:40 3D-models for infectious diseases and vaccines

    Veronique Barban

    Veronique Barban, Expert Virology, Sanofi Pasteur
    View Bio

    • Potential and Limits of 3D-models for industrial development of human vaccines
    • Case study: 2D and 3D liver models for yellow fever virus viscerotropism assessment
     

    12:20 Networking Lunch

    13:20 PANEL DISCUSSION: Adopting new technologies for 3D models

    • An outlook of new and developing technologies for 3D cell culture models
    • Challenges and barriers in the adoption of new technology
    • What is required to make a decision on adoption and what is needed to promote adoption in industry?
     

    Stefan Przyborski

    Stefan Przyborski, Professor of Cell Technology, Durham University
    View Bio

    Philip Hewitt

    Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
    View Bio

    Floriane Groell

    Floriane Groell, (Research Associate of the) Biopharmaceutical Sciences department, University of Geneva
    View Bio

    Samuel Jackson

    Samuel Jackson, Programme Manager, Disease Models, NC3Rs
    View Bio

    Wendy Rowan

    Wendy Rowan, Scientific Director, GSK
    View Bio

    Leonard Both

    Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, Medicines & Healthcare products Regulatory Agency (MHRA)
    View Bio

    14:00 Printing 3D Cell Cultures in Osteoarthritis Research

    Kenny Dalgarno

    Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University
    View Bio

  • Outline the use of bioprinting in two major projects which focus on osteoarthritis:
  • Tissue Engineering & Regenerative Therapies Centre Versus Arthritis
  • CRACK-IT Challenge Project: Printing Osteoarthritis on a Chip
  • Outline the printing approaches taken, and approaches to (i) integration with downstream processes, and (ii) scale-up
  • 14:40 Afternoon Tea

    15:10 C-Stem® technology : 3D microfluidics enabled scale up of culture and differentiation of pluripotent stem cells organoids

    Maxime Feyeux

    Maxime Feyeux, Co-Founder, President, CSO, TreeFrog Therapeutics
    View Bio

    • In vivo like environment allows recapitulation of correct PSC topology
    • Strongly diminished cell death contributes to increased yields
    • Protection from bioreactor mechanical stress allows scale up of PSC culture in standard liquid bioreactors
    • Differentiation of PSC can be achieved within C-Stem™ by leveraging 2D protocols
     

    15:50 Microfluidic technologies for precision medicine in oncology

    Michele Zagnoni

    Michele Zagnoni, Senior Lecturer, University Of Strathclyde
    View Bio

    • Maximising screening of patient tissue
    • Physiological tumour models
    • Microfluidic technologies
    • Precision medicine
     

    16:30 Chairs' Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairs' Opening Remarks

    9:10 Regulatory outlook on 3D Cell Culture Models

    Leonard Both

    Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, Medicines & Healthcare products Regulatory Agency (MHRA)
    View Bio

    • An overview of the applicable regulatory guidelines
    • Validating new technology, relevant quality considerations and regulatory processes
    • Challenges for the traditional regulatory framework
     

    9:50 Addressing unmet needs in 3D cell systems to drive replacement of animal modelling

    Samuel Jackson

    Samuel Jackson, Programme Manager, Disease Models, NC3Rs
    View Bio

  • Much progress has been made in 3D cell model development, to the point that many sub-organ level systems can now be effectively recapitulated in vitro.
  • However, there are several key areas which have yet to be effectively tackled, such as the immune system and tissue vascularization and innervation. 
  • Given that these systems or structures are implicated in most physiological processes and many disease states, making progress on these difficult to tackle topics is key to the future success of 3D modelling approaches.
  • By addressing these areas of unmet need, animal modelling paradigms will increasingly be replaced or augmented with human cell-based systems.

     

  • 10:30 Morning Coffee

    11:00 Reducing attrition in drug discovery through the use of human translational cellular models

    Wendy Rowan

    Wendy Rowan, Scientific Director, GSK
    View Bio

    • The challenge in drug discovery to reduce clinical attrition
    • The new generation of human translational models for use in drug discovery
    • The application and challenges in application of human translational models for drug discovery
    • Looking to the future
     

    11:40 Application of 3D models to ADME research

    Simone Stahl

    Simone Stahl, Associate Principal Scientist, AstraZeneca
    View Bio

  • Importance of physiological features in 3D models for ADME research with a focus on drug transporters
  • Examples of current landscape of ADME 3D models and their applications
  • Transporter characterisation of renal 3D models such as organoids or microfluidic systems
  • Outlook of how ADME 3D models can be applied to drug projects
     
  • 12:20 Networking Lunch

    13:20 3D cell culture model to mimic the human subcutaneous tissue

    Floriane Groell

    Floriane Groell, (Research Associate of the) Biopharmaceutical Sciences department, University of Geneva
    View Bio

  • Development of a 3D cell culture model of the human subcutaneous tissue, allowing the immunogenicity prediction of subcutaneously injected therapeutic proteins.
  • Use of hydrogels as a scaffold to mimic the visco-elastic properties of the human subcutaneous tissue in vitro. Measurement of hydrogels elastic Young's moduli and comparison with ex vivo human samples.
  • Investigation of the hydrogels cytocompatibility with a human myelomonocytic cell line (MUTZ-3) and their influence on cellular phenotype changes
  • 14:00 Visualising the unexpected

    Ellen J Wehrens

    Ellen J Wehrens, Scientific Writer, Princess Maxima Center
    View Bio

    • Advanced 3D imaging can lead to unexpected scientific discoveries
    • Imaging developments and application in advanced 3D culture systems
    • Understanding the efficacy and tumor targeting behavior of immune cell therapy through 3D imaging
    • Future perspective
     

    14:40 Afternoon Tea

    15:10 Development of a high throughput and drug responsive 3D model of white adipose tissue

  • Conception and optimization of a novel biofabrication workflow for the development of 3D tissue models i.e. the bioprinting and dispensing of matrix-based cellular constructs under oil prior to media transfer 
  • A joint collaboration between OxSyBio and MRC Harwell led to the development of a 3D white adipose tissue (WAT) model for mechanistic studies of metabolic diseases
  • Extensive characterization of the adipogenic spheroid (i.e. the 3D WAT) revealed the model was reproducible, highly differentiated, had active lipid metabolism and was drug-responsive
  • Establishment of high throughput monitoring of drug-effects on 3D WAT models on a 96-well scale. Specifically, using high content-imaging of lipid phenotype and time-course metabolite measurements
  • Rajesh  Pandey

    Rajesh Pandey, Postdoctoral Training Fellow, MRC Harwell Institute
    View Bio

    Alexander D. Graham

    Alexander D. Graham, Investigator Scientist, MRC Harwell Institute
    View Bio

    16:30 Chairs' Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Alexander D. Graham

    Alexander D. Graham

    Investigator Scientist, MRC Harwell Institute
    Ellen J Wehrens

    Ellen J Wehrens

    Scientific Writer, Princess Maxima Center
    Floriane Groell

    Floriane Groell

    (Research Associate of the) Biopharmaceutical Sciences department, University of Geneva
    Jason Ekert

    Jason Ekert

    Head of Complex In Vitro Models, GlaxoSmithKline
    Kenny Dalgarno

    Kenny Dalgarno

    Professor of Manufacturing Engineering, Newcastle University
    Leonard Both

    Leonard Both

    Senior Quality Assessor, Biologicals/Biotechnology Unit, Medicines & Healthcare products Regulatory Agency (MHRA)
    Maxime Feyeux

    Maxime Feyeux

    Co-Founder, President, CSO, TreeFrog Therapeutics
    Michele Zagnoni

    Michele Zagnoni

    Senior Lecturer, University Of Strathclyde
    Philip Hewitt

    Philip Hewitt

    UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
    Rajesh  Pandey

    Rajesh Pandey

    Postdoctoral Training Fellow, MRC Harwell Institute
    Samuel Jackson

    Samuel Jackson

    Programme Manager, Disease Models, NC3Rs
    Simone Stahl

    Simone Stahl

    Associate Principal Scientist, AstraZeneca
    Stefan Przyborski

    Stefan Przyborski

    Professor of Cell Technology, Durham University
    Veronique Barban

    Veronique Barban

    Expert Virology, Sanofi Pasteur
    Wendy Rowan

    Wendy Rowan

    Scientific Director, GSK

    Alexander D. Graham

    Investigator Scientist, MRC Harwell Institute
    Alexander D. Graham

    Dr Alexander Graham, an Investigator Scientist at MRC Harwell Institute, is a biofabrication specialist with 8 years of experience in bioprinting and 3D tissue models. During his doctoral studies at the University of Oxford (Hagan Bayley group), he co-invented a high-resolution drop-on-demand 3D bioprinter of cellular components and living mammalian cells. This work set the scientific foundation for synthetic tissue company OxSyBio (UK, 2014-2019), where Alex led biofabrication developments. This included a successful collaboration with MRC Harwell Institute on the development of a high throughput 3D model of white adipose tissue for use in mechanistic studies of metabolic diseases.

    Ellen J Wehrens

    Scientific Writer, Princess Maxima Center
    Ellen J Wehrens

    After obtaining her PhD in immunology, Ellen Wehrens received a postdoctoral fellowship to study T cell regulation in the context of chronic infection at the University of California San Diego (UCSD). She soon discovered that next to a broad research interest, she had a strong passion for scientific communication. Now working at the Princes Máxima Center for Pediatric Oncology in the group of Anne Rios, Ellen hopes to advance research into childhood cancer and the work of the Rios group in particular, by preparing funding applications, writing scientific manuscripts and engaging the community into the fight against pediatric cancer.

    Floriane Groell

    (Research Associate of the) Biopharmaceutical Sciences department, University of Geneva
    Floriane Groell

    Floriane Groell is currently a Senior Scientist within the Cell and Gene Therapies Development department at Novartis, in Basel (Switzerland).
    She holds a PhD in Biopharmaceutical Sciences from the University of Geneva. During her thesis at the Geneva-Lausanne School of Pharmaceutical Sciences (EPGL), she worked on the biophysical characterization of therapeutic proteins aggregates applying 3D subcutaneous cell culture models for immunogenicity assessment. Before her doctoral studies, Floriane graduated her Master in Biotechnology from the University of Technology of Compiègne (France). She holds a Bachelor degree in Biochemistry from the University Claude Bernard Lyon 1 (France).
    Floriane grew up near Chamonix Mont-Blanc. She likes hiking and skiing, and finds peace of mind in yoga practice now for over 10 years.
     

    Jason Ekert

    Head of Complex In Vitro Models, GlaxoSmithKline
    Jason Ekert

    I head the Complex In Vitro Models group in the R&D Platform Technology & Sciences organization at GlaxoSmithKline. I lead an integrated enterprise strategy for sustained, portfolio driven growth in R&D applications of human-relevant and translatable complex in vitro models (eg Spheroids, Organoids, MPS and bioprinting). Before coming to GSK I spent 11 years at Janssen BioTherapeutics in early biotherapeutic drug discovery in target discovery, drug validation and MOA studies applying complex cell-based assays across multiple therapeutic areas. My current focus at GSK is to improve predictive validity of early preclinical models leading to better characterized molecules, decreased R&D cycle time and a reduction in attrition.

    Kenny Dalgarno

    Professor of Manufacturing Engineering, Newcastle University
    Kenny Dalgarno

    Kenny Dalgarno is Sir James Woodeson Professor of Manufacturing Engineering at Newcastle University, and is Deputy Director of the Arthritis Research UK Tissue Engineering Centre, Deputy Director of the UK EPSRC Centre for Innovative Manufacture in Medical Devices, the Newcastle University lead investigator for the UK EPSRC Centre for Doctoral Training in Additive Manufacture and 3D Printing. He researches in the area of additive manufacture and biofabrication, with an increasing emphasis on applications in biomedical engineering, tissue engineering, and regenerative medicine, with work supported by the EPSRC, the European Commission, Arthritis Research UK, the NC3Rs, and industry.

    Leonard Both

    Senior Quality Assessor, Biologicals/Biotechnology Unit, Medicines & Healthcare products Regulatory Agency (MHRA)
    Leonard Both

    Dr Leonard Both is a Senior quality assessor at the Medicines and Healthcare products Regulatory Agency (MHRA) in London, UK. He works in the Biologicals & Biotechnology Unit of the MHRA Licensing Division. Before joining MHRA, he performed quality assessments of diagnostics at Public Health England (PHE, previously called the Health Protection Agency) and worked at the European Medicines Agency (EMA). He is a board member of the Control Programme Board (CPB) at the National Institute of Biological Standards and Controls (NIBSC). Leonard holds a PhD degree in molecular immunology from the University of London.

    Maxime Feyeux

    Co-Founder, President, CSO, TreeFrog Therapeutics
    Maxime Feyeux

    An Ecole Normale graduate and PhD, Maxime has 16 years of experience in the field of pluripotent stem cells. Maxime defended his thesis at I-Stem, the French reference lab for pluripotent cells, in 2011 and went on to conduct postdoctoral studies in Geneva, where he also took a Business Creation course. He came back to France in 2015 to develop what would become the founding technology of Treefrog Therapeutics and co-founded the company in 2018 as CSO and Chairman of the company.

    Michele Zagnoni

    Senior Lecturer, University Of Strathclyde
    Michele Zagnoni

    Dr Michele Zagnoni leads a multidisciplinary research group focussed on the development of microfluidic technologies for healthcare applications, including fundamental biological research, drug screening, personalized medicine therapy, organ-on-a-chip and synthetic biology (www.zagnonilab.com). He is the co-founder and Chief Scientific Officer of ScreenIn3D.

    Philip Hewitt

    UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
    Philip Hewitt

    ?I originally trained as a Medical Biochemist at the University of Birmingham (1986-1989). I worked as a Research Assistant in the Pharmacology and Toxicology Department at Imperial College, London where I received my PhD in the lab of Dr Sharon Hotchkiss. The main theme of the research project was “percutaneous absorption: metabolic and kinetic parameters”. In 1996, I transferred to The University of California, San Francisco, in the Dermatology Department; I spent 18 months there under the guidance of Prof. Howard Maibach. In 1998 I started a permanent position in the Institute of Toxicology at Merck KGaA in Germany, where I established the Molecular Toxicology Group. I am currently responsible for early cytotoxicity screening, hepatotoxicity methods, biomarker monitoring, CYP induction studies, genotoxicity testing and cytokine screening. I work with several PhD students, on external collaborative projects and I am team representative on several internal pharmaceutical projects.

    Rajesh Pandey

    Postdoctoral Training Fellow, MRC Harwell Institute
    Rajesh  Pandey

    Rajesh has research experience spanning genomics, population genetics, non-coding RNA, microbiome, mouse models and 3D Spheroids. During his doctoral studies from Institute of Genomics and Integrative Biology (India), he explored and elucidated the role of non-coding RNA in genome regulation during stress response. Post-PhD, at Johns Hopkins University and Translational Research and Innovative Science ThRough Ayurgenomics, India, he discovered genomic, microbial and molecular correlates for endo-phenotypes within homogenous populations. At MRC Harwell Institute, he is working towards developing a high-throughput 3D Spheroid model of White Adipose tissue to elucidate molecular mechanism of metabolic disorders with future drug screening potential.

    Samuel Jackson

    Programme Manager, Disease Models, NC3Rs
    Samuel Jackson

    Dr Jackson was awarded a PhD in Neurobiology in 2004 for work studying the role of the cannabinoid system in neurodegeneration related to multiple sclerosis. During postdoctoral positions at the University of Wisconsin – Madison, UCL and QMUL, he developed and employed animal and in vitro models of demyelinating disease to probe therapeutic approaches to remyelination and neuroprotection. Following 3 years at Eli Lilly working on the neurobiology and treatment of Alzheimer’s disease, Dr Jackson left the lab to apply his knowledge of animal and alternative modelling at the NC3Rs. He is currently managing a programme of work to enable the development and uptake of human tissue based models, microphysiological systems and other alternative methods to diverse research areas, including cancer and safety pharmacology.

    Simone Stahl

    Associate Principal Scientist, AstraZeneca
    Simone Stahl

    Simone Stahl completed her PhD in tumour immunology at the German Cancer Research Centre in Heidelberg. She joined AstraZeneca’s safety function initially in Alderley Park then Cambridge, UK. In Molecular Toxicology Simone contributed to AstraZeneca’s preclinical hepatotoxicity strategy developing in vitro models for hepatic and other organ toxicities. She has since continued to gain expertise in drug transporters and their role in organ injury, drug disposition and drug drug interactions. In ADME Sciences Simone champions the evaluation of novel in vitro systems for DMPK applications. Throughout her career Simone supported investigative programs for drug projects from the toxicity as well as ADME perspective.

    Stefan Przyborski

    Professor of Cell Technology, Durham University
    Stefan Przyborski

    Professor Przyborski holds an academic position as Professor in Cell Technology at Durham University. He has over 25 years experience in cell biology with specific interests in cell culture technology, tissue engineering and stem cell research. In recent years he has developed a multi-disciplinary approach through collaborative projects with physical scientists to develop novel ways of solving biological problems. He has formed alliances with pharmaceutical and biotech companies, has published over 110 scientific papers and has filed several patents. He is also the founder and Chief Scientific Officer of Reinnervate (now part of Reprocell Europe), a biotechnology company founded in 2002 as a spinout from Durham University UK. Professor Przyborski is developing new and innovative ways to manage the growth and function of cultured cells. These enabling technologies have multiple applications and will be particularly relevant to bioengineering models of human tissues to advance basic research and drug discovery.

    Veronique Barban

    Expert Virology, Sanofi Pasteur
    Veronique Barban

    Virology Expert in the global Research & Non-Clinical Safety Department of Sanofi Pasteur
    Training /expertise: Molecular and Cellular Virologist with 30 years of experience in Vaccine Research in Pharmaceutical Industry. Contribution to conception, evaluation and development of live-attenuated viral vaccines for human use. Large expertise in vaccines against flavivirus infection, including 15 years on the development of DengVaxia, the first licenced vaccine against dengue (authoring and co-authoring of several publications and patents on vaccine development and characterization). Main other expertise areas include Yellow Fever, Japanese Encephalitis and Zika viruses, Hepatitis A and C infection, SRAS, CMV and HIV (canaripox vectors)
    Current centres of interest: Since few years, growing interest in animal substitution (3Rs) and in vitro cellular models able to mimic some aspects of viral pathogenesis
     

    Wendy Rowan

    Scientific Director, GSK
    Wendy Rowan

    I started my career at Guy’s Hospital Medical School, before transitioning to industry. I have worked for GSK and its legacy companies for over thirty years. Immunology has been a common theme throughout my career, working on aspects of both innate and adaptive immunity in respiratory and autoimmune diseases. In April 2019, I joined the Novel Human Genetics Research Unit with a focus on using genetics to guide target selection for drug discovery. With the aim of reducing attrition in drug discovery, I have a long standing interest in developing and accessing better human translational models for target validation, lead discovery and candidate selection, including safety assessment and PK/PD profiling.

    Official Media Partner

    Supporters

    Focus Days

    3D Bioprinting Focus Day
    Focus Day

    3D Bioprinting Focus Day

    Copthorne Tara Hotel
    18th February 2020
    London, United Kingdom

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Full Programme

    Download

    2020 Conference Speakers

    Download

    Focus Day 3D Bioprinting

    Download

    3D Cell Culture Brochure 2020

    Download

    Past Attendees 2017-2019

    Download

    2019 - 'Novel approaches to study cell health and signalling in 3D microtissues' by Marta Rucka - Promega

    Download

    2019- 'Metabolic equilibrium in 3D environments: a key to stable, reproducible, mimetic tissues' by Krzysztof Wrzesinski- CelViv

    Download

    2019 - 'From the Well to the Cell: Novel Technologies for Imaging and Analysis in 3D Cell Culture Workflows' by Wouter Strijker-

    Download

    2019 - 'Tools, not Toys: From Innovation to Regulatory Application' by William B. Mattes - FDA US

    Download

    2019- 'Crack-it:Development of 3D eye models for early assessment of retinal toxicity' by Phil Hewitt - Merck

    Download

    Media Partners


    Genetic Engineering News

    Official Media Partner
    http://www.genengnews.com

    Genetic Engineering & Biotechnology News (GEN) is the most authoritative and widely read biotechnology news publication in the world.Published 21 times a year,GEN's unique news and technology focus include the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drugs and biomarker discovery, bioprocessing, clinical research, molecular diagnostics and biobusiness. For a free subscription go to: http://www.genengnews.com/subscriptions.aspx


    Labiotech.eu

    Official Media Partner
    https://goo.gl/DRE2Gp

    Labiotech.eu is the leading digital media covering the European Biotech industry. Over 100,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!

    Media Partners


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    MedTube

    Supporters
    https://medtube.net/



    BioChem Adda

    Supporters
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    IPI

    Supporters
    http://www.ipimediaworld.com

    IPI – International Pharmaceutical Industry Established by professionals with over 30 years experience in the Pharmaceutical and Life sciences publishing sectors. We have identified the needs of these dynamic industries, and have listened carefully to our readers and advertisers. With strong collaboration between Pharmaceutical and Life sciences Industry Associations we have created a global distribution network. We give you a promise to become a reliable extension of your marketing and communication arm. If necessary we will integrate our expertise with your needs. Incorporating new and innovative communication methods we will help to highlight your expertise.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out